|
Type:
|
Approved drug |
|
PubChem:
|
5073
|
|
DrugBank:
|
DB00734
|
|
IUPAC:
|
3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one |
|
Standard InChI:
|
InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3 |
|
Standard InChIKey:
|
RAPZEAPATHNIPO-UHFFFAOYSA-N |
|
SMILES:
|
CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1 |
|
Metabolism-related information:
|
Inducting symptoms of Parkinson’s disease
|
|
Reference:
|
10.1517/17425255.2016.1121234 |
